Latest Insider Transactions at Horizon Therapeutics Public LTD CO (HZNP)
This section provides a real-time view of insider transactions for Horizon Therapeutics Public LTD CO (HZNP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Horizon Therapeutics Public Ltd Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Horizon Therapeutics Public Ltd Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2016
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,100
-2.67%
|
$82,000
$20.0 P/Share
|
|
Feb 19
2016
|
Robert Carey EVP, Chief Business Officer |
BUY
Bona fide gift
|
Indirect |
24,406
+22.92%
|
-
|
|
Feb 19
2016
|
Robert Carey EVP, Chief Business Officer |
SELL
Bona fide gift
|
Direct |
24,406
-100.0%
|
-
|
|
Jan 02
2016
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
30,845
-10.73%
|
$647,745
$21.67 P/Share
|
|
Jan 02
2016
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
81,675
+22.13%
|
-
|
|
Jan 02
2016
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,576
-5.28%
|
$180,096
$21.67 P/Share
|
|
Jan 02
2016
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,750
+14.15%
|
-
|
|
Jan 02
2016
|
Brian K Beeler EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,741
-12.41%
|
$78,561
$21.67 P/Share
|
|
Jan 02
2016
|
Brian K Beeler EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
11,200
+27.09%
|
-
|
|
Dec 15
2015
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,442
+10.65%
|
$91,326
$3.68 P/Share
|
|
Dec 11
2015
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,082
+1.0%
|
$8,328
$4.96 P/Share
|
|
Dec 10
2015
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Open market or private sale
|
Direct |
4,456
+4.07%
|
$89,120
$20.0 P/Share
|
|
Dec 08
2015
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,752
-3.31%
|
$78,792
$21.4 P/Share
|
|
Dec 08
2015
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,208
+6.75%
|
-
|
|
Dec 08
2015
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,178
-6.93%
|
$318,738
$21.4 P/Share
|
|
Dec 08
2015
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,211
+13.17%
|
-
|
|
Dec 01
2015
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,628
-20.94%
|
$55,188
$21.3 P/Share
|
|
Dec 01
2015
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,450
+40.24%
|
-
|
|
Nov 24
2015
|
John J Kody EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,209
-32.72%
|
$130,389
$21.68 P/Share
|
|
Nov 24
2015
|
John J Kody EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,975
+50.0%
|
-
|
|
Sep 21
2015
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,750
-6.87%
|
$240,250
$31.78 P/Share
|
|
Sep 19
2015
|
William F Daniel Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
2,381
-30.24%
|
$73,811
$31.92 P/Share
|
|
Sep 19
2015
|
William F Daniel Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
7,874
+50.0%
|
-
|
|
Sep 12
2015
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,794
-11.23%
|
$50,232
$28.99 P/Share
|
|
Sep 12
2015
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,925
+19.72%
|
-
|
|
Aug 19
2015
|
Thomas Watkins Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$310,000
$31.32 P/Share
|
|
Jul 15
2015
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
26,887
-9.96%
|
$941,045
$35.55 P/Share
|
|
Jul 15
2015
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,887
+8.59%
|
$80,661
$3.68 P/Share
|
|
Jun 23
2015
|
Paul W. Hoelscher EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,799
-44.0%
|
$299,166
$34.27 P/Share
|
|
Jun 23
2015
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
-
|
|
May 19
2015
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,270
-40.32%
|
$210,830
$29.22 P/Share
|
|
May 19
2015
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,075
+47.13%
|
-
|
|
May 01
2015
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
86,598
+12.74%
|
$692,784
$8.38 P/Share
|
|
Mar 13
2015
|
Jeff Himawan Director |
SELL
Open market or private sale
|
Indirect |
357,287
-100.0%
|
$7,860,314
$22.35 P/Share
|
|
Mar 12
2015
|
Jeff Himawan Director |
SELL
Open market or private sale
|
Indirect |
197,277
-35.57%
|
$4,340,094
$22.59 P/Share
|
|
Mar 12
2015
|
Jeff Himawan Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
135,805
-19.67%
|
$543,220
$4.04 P/Share
|
|
Mar 12
2015
|
Jeff Himawan Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
690,369
+50.0%
|
$2,761,476
$4.31 P/Share
|
|
Mar 10
2015
|
Jeff Himawan Director |
SELL
Open market or private sale
|
Indirect |
1,284,915
-100.0%
|
$26,983,215
$21.84 P/Share
|
|
Mar 09
2015
|
Jeff Himawan Director |
SELL
Open market or private sale
|
Indirect |
329,912
-20.43%
|
$6,928,152
$21.91 P/Share
|
|
Mar 05
2015
|
Robert Carey EVP, Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,736
-29.52%
|
$194,720
$20.84 P/Share
|
|
Mar 05
2015
|
Robert Carey EVP, Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,025
+48.47%
|
-
|
|
Jan 02
2015
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,353
-22.94%
|
$316,236
$12.8 P/Share
|
|
Jan 02
2015
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
81,675
+41.55%
|
-
|
|
Jan 02
2015
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,753
-7.88%
|
$105,036
$12.8 P/Share
|
|
Jan 02
2015
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,750
+19.41%
|
-
|
|
Dec 08
2014
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,065
-29.75%
|
$168,780
$12.99 P/Share
|
|
Dec 08
2014
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,210
+41.26%
|
-
|
|
Dec 08
2014
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,656
-3.05%
|
$31,872
$12.99 P/Share
|
|
Dec 08
2014
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,208
+8.62%
|
-
|
|
Nov 19
2014
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
150,000
-91.43%
|
$1,800,000
$12.05 P/Share
|